1,533
Views
22
CrossRef citations to date
0
Altmetric
Original Research Article

Human brucellosis among pyrexia of unknown origin cases and occupationally exposed individuals in Goa Region, India

, , , , , , , , , & show all
Article: 23846 | Received 18 Jan 2014, Accepted 26 Mar 2014, Published online: 25 Jan 2017

References

  • Pappas G, Papadimitriou P, Akritidis N, Christou L, Tsianos EV. The new global map of human brucellosis. Lancet Infect Dis. 2006; 6: 91–99. [PubMed Abstract].
  • Corbel MJ. Brucellosis in humans and animals. 2006; Geneva, Switzerland: World Health Organization.
  • Mantur BG, Biradar MS, Bidri RC, Mulimani MS, Veerappa, Kariholu P. Protean clinical manifestations and diagnostic challenges of human brucellosis in adults: 16 years’ experience in an endemic area. J Med Microbiol. 2006; 55: 897–903. [PubMed Abstract].
  • Ciftçi E, Ince E, Doğru U. Pyrexia of unknown origin in children: a review of 102 patients from Turkey. Ann Trop Paediatr. 2003; 23: 259–263.
  • Baba MM, Sarkindared SE, Brisibe F. Serological evidence of brucellosis among predisposed patients with pyrexia of unknown origin in the north eastern Nigeria. Cent Eur J Public Health. 2001; 9: 158–161. [PubMed Abstract].
  • Radostits OM, Gay CC, Hinchcliff KW, Constable PD. Veterinary medicine: a textbook of the diseases of cattle, horses, sheep, pigs and goats. 2007; Philadelphia, PA: W. B. Saunders.963–984. 10th ed.
  • Godfroid J, Cloeckaert A, Liautard JP, Kohler S, Fretin D, Walravens K. From the discovery of the Malta fever's agent to the discovery of a marine mammal reservoir, brucellosis has continuously been a re-emerging zoonosis. Vet Res. 2005; 36: 313–326. [PubMed Abstract].
  • Rubio M, Barrio B, Díaz R. Usefulness of rose Bengal, coombs and counter-immunoelectrophoresis for the diagnosis of human brucellosis cases with negative seroagglutination. Enferm Infecc Microbiol Clin. 2001; 19: 406–407. [PubMed Abstract].
  • Mantur B, Parande A, Amarnath S, Patil G, Walvekar R, Desai A. ELISA versus conventional methods of diagnosing endemic brucellosis. Am J Trop Med Hyg. 2010; 83: 314–318. [PubMed Abstract] [PubMed CentralFull Text].
  • Islam MA, Khatun MM, Werre SR, Sriranganathan N, Boyle SM. A review of Brucella seroprevalence among humans and animals in Bangladesh with special emphasis on epidemiology, risk factors and control opportunities. Vet Microbiol. 2013; 166: 317–326. [PubMed Abstract].
  • Al Dahouk S, Nöckler K. Implications of laboratory diagnosis on brucellosis therapy. Expert Rev Anti Infect Ther. 2011; 9(7): 833–845. [PubMed Abstract].
  • Baily GG, Krahn JB, Drasar BS, Stoker NG. Detection of Brucella melitensis and Brucella abortus by DNA amplification. J Trop Med Hyg. 1992; 95(4): 271–275. [PubMed Abstract].
  • Bounaadja L, Albert D, Chénais B, Hénault S, Zygmunt MS, Poliak S. Real-time PCR for identification of Brucella spp.: a comparative study of IS711, bcsp31 and per target genes. Vet Microbiol. 2009; 137: 156–164. [PubMed Abstract].
  • Alton GG, Jones LM, Pietz DE. Laboratory techniques in brucellosis. 1975; Geneva, Switzerland: World Health Organization. 2nd ed.
  • Agasthya AS, Isloor S, Krishnamsetty P. Seroprevalence study of human brucellosis by conventional tests and indigenous indirect enzyme-linked immunosorbent assay. ScientificWorldJournal. 2012; 2012: 104239. [PubMed Abstract] [PubMed CentralFull Text].
  • Hénault S, Calvez D, Thiébaud M, Bouličre M, Garin-Bastuji B. Validation of a nested-PCR based on the IS6501/711 sequence for the detection of Brucella in animal samples. 2000. Proceedings of the Brucellosis 2000 International Research Conference 9I including the 53rd Brucellosis Research Conference, September 7–9; Nimes, France. Paris: INRA.
  • Renukaradhya GJ, Isloor S, Rajasekhar M. Epidemiology, zoonotic aspects, vaccination and control/eradication of brucellosis in India. Vet Microbiol. 2002; 90: 183–195. [PubMed Abstract].
  • Smits HL, Kadri SM. Brucellosis in India: a deceptive infectious disease. Indian J Med Res. 2005; 122: 375–384. [PubMed Abstract].
  • Mantur BG, Amarnath SK. Brucellosis in India—a review. J Biosci. 2008; 33: 539–547. [PubMed Abstract].
  • Agasthya AS, Isloor S, Prabhudas K. Brucellosis in high risk group individuals. Indian J Med Microbiol. 2007; 25(1): 28–31. [PubMed Abstract].
  • Mangalgi SS, Sajjan AG, Mohite ST. Brucellosis: a cause of pyrexia of unknown origin. Int J Bio Med Res. 2012; 3: 2054–2058.
  • Handa R, Singh S, Singh N, Wali JP. Brucellosis in north India: results of a prospective study. J Commun Dis. 1998; 30: 85–87. [PubMed Abstract].
  • Kadri SM, Rukhsana A, Laharwal MA, Tanvir M. Seroprevalence of brucellosis in Kashmir (India) among patients with pyrexia of unknown origin. J Indian Med Assoc. 2000; 98: 170–171. [PubMed Abstract].
  • Ali S, Ali Q, Neubauer H, Melzer F, Elschner M, Khan I. Seroprevalence and risk factors associated with brucellosis as a professional hazard in Pakistan. Foodborne Pathog Dis. 2013; 10: 500–505. [PubMed Abstract].
  • Memish ZA, Balkhy HH. Brucellosis and international travel. J Travel Med. 2004; 11: 49–55. [PubMed Abstract].
  • Gómez MC, Nieto JA, Rosa C, Geijo P, Escribano MA, Muñoz A. Evaluation of seven tests for diagnosis of human brucellosis in an area where the disease is endemic. Clin Vaccine Immunol. 2008; 15: 1031–1033.